Target intelligence / Profile preview

Greater splanchnic nerve

Molecular classification
Other (Peripheral nerve, not a molecular target), Component of the autonomic nervous system (sympathetic division)
01

Overview

The **greater splanchnic nerve** is a major component of the thoracic splanchnic nerves, arising from the medial branches of the fifth through ninth thoracic sympathetic ganglia. It descends along the anterior surface of the spine, passes through the diaphragm, and terminates primarily at the celiac ganglia. The greater splanchnic nerve carries preganglionic sympathetic fibers that provide autonomic innervation to foregut structures including the liver, gallbladder, spleen, stomach, pancreas, duodenum, and also sends fibers to stimulate catecholamine release from the adrenal medulla. Its main functions are modulation of visceral activity—such as inhibiting gut motility and secretions—and regulation of vascular tone within its target organs[1][2][3][5]. **Note:** The greater splanchnic nerve is an *anatomical structure*—a peripheral mixed autonomic/sensory nerve—not a molecular therapeutic target such as a receptor or enzyme. It does not fit standard drug-target classifications used in pharmacology databases; thus "is_target" should be marked false and "is_incorrect" true for purposes where only molecular targets are relevant[1][2].

Other names
Greater thoracic splanchnic nerveNervus splanchnicus majorThoracic splanchnic nerve (greater)
02

Biological functions

Sympathetic innervation of abdominal organsModulation of enteric nervous system activity in the foregutRegulation of blood flow to abdominal visceraStimulation of adrenal medulla for catecholamine release
03

Disease associations

Other (May be involved in pain syndromes or targeted in certain surgical procedures, but not a direct disease mediator like a receptor or enzyme)
04

Safety considerations

Potential complications from surgical ablation or injury include impaired sympathetic regulation of abdominal organs and possible hypotension.Loss of sympathetic tone may affect gastrointestinal motility and blood flow.

Beyond the preview

Go deeper on Greater splanchnic nerve.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Greater splanchnic nerve.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call